Skip to main content

Table 4 Main characteristics of the principal medicines provision system in place in Brazil. 2015

From: Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the “Farmácia popular” program in Brazil: an interrupted time series study

Aspect Medicines Provision System
Farmácia Popular – government owned dispensing facilities Farmacia Popular – covenantal private pharmacies Public health care dispensing facilities Out-of-pocket (private pharmacies and outlets)
Management Oswaldo Cruz Foundation (Fiocruz) Department of Pharmaceuticals – Ministry of Health Decentralized, mostly at Municipality level Private
Dispensing / selling facilities Managed by government organizations (e.g. Municipality Health Secretariats, University Hospitals, NGOs), covenant with Fiocruz Private pharmacies covenanted with the MoH Public dispensing facilities, generally located inside health care facilities Private pharmacies and pharmaceutical outlets
Procurement Managed by Fiocruz through open bid Private pharmacies Each government level. Primary health care medicines are mostly procured at Municipality level, except medicines to endemic diseases, which are central procured by the MoH Private pharmacies
Reference list Yes, 41 therapeutic groups, 117 items Yes, 9 therapeutic groups, 117 items Yes, NEML (Rename) No
Clients/ prescription Anyone Anyone Generally, only prescriptions from a public health facility is accepted Anyone
Payment Fixed price
antihypertensive, antidiabetics and antiashmatic medicines are free-of-charge to patients since 2011
90% of reference price paid by the government, difference paid by the patient (it occurs that selling price is bigger than reference price).
100% is paid by the government for antihypertensive, antidiabetics and antiasthmatic medicines since 2011
Free-of-charge to patients Out-of-pocket
Maximum retail price defined by the regulatory agency (Anvisa)
  1. Source: Adapted from Silva, 2014 [32]